Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15
Satoshi Inoue(University of Leicester), Tak W. Mak(University Health Network), Bryan E. Snow(University Health Network), Jennifer Silvester(Ontario Institute for Cancer Research), Linda Z. Penn(Princess Margaret Cancer Centre), Jillian Haight(University Health Network), Danny Ghazarian(Toronto General Hospital), Andrew Wakeham(Ontario Institute for Cancer Research), Chiara Gorrini(Princess Margaret Cancer Centre), Takeshi Ueda(Shimada Municipal Hospital), Wanda Y. Li(Ontario Institute for Cancer Research), Susan McCracken(Kettering University), Gerry Melino(University of Rome Tor Vergata), Momoe Itsumi(Kawasaki Medical School), David W. Cescon(Princess Margaret Hospital), Carmen Dominguez‐Brauer(University Health Network), Isaac S. Harris(University of Rochester Medical Center), Andrew Elia(Ontario Institute for Cancer Research), Iok In Christine Chio(Cancer Genetics (United States)), Masato Sasaki(Daiichi-Sankyo (Japan)), Zhenyue Hao(Princess Margaret Cancer Centre), Kazuo Yamamoto(Nagasaki University), Annick You-Ten(Ontario Institute for Cancer Research), Lily Zhou(Precision Nanosystems (Canada))
Cited by 137
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Serine and glycine metabolism in cancer
|Trends in Biochemical Sciences|2014|1.1k
Regulation of tumour necrosis factor signalling: live or let die
|Nature reviews. Immunology|2015|994